ATE403643T1 - 6-(aryl-amido oder aryl-amidomethyl)-naphthol-2- yloxy-säurederivate als inhibitoren des plasminogen aktivator inhibitors typ-1(pai-1) - Google Patents
6-(aryl-amido oder aryl-amidomethyl)-naphthol-2- yloxy-säurederivate als inhibitoren des plasminogen aktivator inhibitors typ-1(pai-1)Info
- Publication number
- ATE403643T1 ATE403643T1 AT02746561T AT02746561T ATE403643T1 AT E403643 T1 ATE403643 T1 AT E403643T1 AT 02746561 T AT02746561 T AT 02746561T AT 02746561 T AT02746561 T AT 02746561T AT E403643 T1 ATE403643 T1 AT E403643T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- amidomethyl
- pai
- naphthol
- amido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29965201P | 2001-06-20 | 2001-06-20 | |
US30865601P | 2001-07-30 | 2001-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE403643T1 true ATE403643T1 (de) | 2008-08-15 |
Family
ID=26971330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02746561T ATE403643T1 (de) | 2001-06-20 | 2002-06-18 | 6-(aryl-amido oder aryl-amidomethyl)-naphthol-2- yloxy-säurederivate als inhibitoren des plasminogen aktivator inhibitors typ-1(pai-1) |
Country Status (12)
Country | Link |
---|---|
US (1) | US6589970B2 (de) |
EP (1) | EP1397341B1 (de) |
JP (1) | JP4394949B2 (de) |
CN (1) | CN100467443C (de) |
AR (1) | AR036099A1 (de) |
AT (1) | ATE403643T1 (de) |
BR (1) | BR0210468A (de) |
CA (1) | CA2450174A1 (de) |
DE (1) | DE60228079D1 (de) |
MX (1) | MXPA03011409A (de) |
TW (1) | TW591020B (de) |
WO (1) | WO2003000649A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7291639B2 (en) * | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
ATE482747T1 (de) * | 2003-04-11 | 2010-10-15 | High Point Pharmaceuticals Llc | Neue amide derivate und deren pharmazeutische verwendungen |
US7446201B2 (en) * | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7265148B2 (en) * | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7534894B2 (en) * | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
WO2005080367A1 (en) * | 2004-02-12 | 2005-09-01 | Pharmagene Laboratories Limited | Ep2 receptor agonists |
US7754747B2 (en) * | 2004-08-23 | 2010-07-13 | Wyeth Llc | Oxazolo-naphthyl acids |
AU2005277139A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
DE102004051277A1 (de) * | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclische Carbonylverbindungen |
US7214704B2 (en) * | 2004-11-15 | 2007-05-08 | Bristol-Myers Squibb Company | 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
US7223786B2 (en) * | 2004-11-15 | 2007-05-29 | Bristol-Myers Squibb Company | 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
US7365061B2 (en) * | 2004-11-15 | 2008-04-29 | Bristol-Myers Squibb Company | 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
US7226942B2 (en) | 2004-11-15 | 2007-06-05 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
CN101111491A (zh) * | 2005-01-27 | 2008-01-23 | 惠氏公司 | 用于制备被取代的萘基吲哚衍生物的方法和化合物 |
KR101394245B1 (ko) | 2005-12-30 | 2014-05-14 | 에스케이바이오팜 주식회사 | 아이속사졸 유도체 및 이의 용도 |
JP2009528290A (ja) * | 2006-02-27 | 2009-08-06 | ワイス | 筋肉病の処置のためのpai−1阻害剤 |
JP5374840B2 (ja) | 2006-07-20 | 2013-12-25 | Jnc株式会社 | カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途 |
PL2069332T3 (pl) | 2006-08-15 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Związki azetydynowe jako antagoniści receptorów oreksynowych |
WO2008044729A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivative |
US7884234B2 (en) * | 2006-10-12 | 2011-02-08 | Institute Of Medicinal Molecular Design, Inc. | N-phenyloxamide derivatives |
EP2262497A2 (de) * | 2008-03-17 | 2010-12-22 | Allergan, Inc. | S1p3-rezeptor-inhibitoren zur behandlung von entzündungen |
US8633245B2 (en) * | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
WO2009125606A1 (ja) | 2008-04-11 | 2009-10-15 | 株式会社医薬分子設計研究所 | Pai-1阻害剤 |
CA2801778C (en) | 2010-06-07 | 2018-06-05 | Novomedix, Llc | Furanyl compounds and the use thereof |
WO2012039972A1 (en) | 2010-09-21 | 2012-03-29 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition |
CA2997549C (en) * | 2015-09-04 | 2023-10-03 | Shin Poong Pharmaceutical Co., Ltd. | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0648208A1 (de) | 1993-04-05 | 1995-04-19 | Fujisawa Pharmaceutical Co., Ltd. | Indol derivate als restosteron 5 alpha-reductase inhibitoren |
ES2103181B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Amidas naftalenicas con accion antagonista de los leucotrienos. |
GB9402807D0 (en) | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
DE4404662C2 (de) * | 1994-02-14 | 1997-10-23 | Windmoeller & Hoelscher | Abreißwalzenpaar |
WO2000031045A1 (fr) | 1998-11-20 | 2000-06-02 | Torii Pharmaceutical Co., Ltd. | Derives de naphtalene |
-
2002
- 2002-06-10 TW TW091112528A patent/TW591020B/zh not_active IP Right Cessation
- 2002-06-13 US US10/170,558 patent/US6589970B2/en not_active Expired - Fee Related
- 2002-06-18 MX MXPA03011409A patent/MXPA03011409A/es active IP Right Grant
- 2002-06-18 AT AT02746561T patent/ATE403643T1/de not_active IP Right Cessation
- 2002-06-18 CA CA002450174A patent/CA2450174A1/en not_active Abandoned
- 2002-06-18 JP JP2003506853A patent/JP4394949B2/ja not_active Expired - Fee Related
- 2002-06-18 CN CNB028161866A patent/CN100467443C/zh not_active Expired - Fee Related
- 2002-06-18 EP EP02746561A patent/EP1397341B1/de not_active Expired - Lifetime
- 2002-06-18 WO PCT/US2002/019193 patent/WO2003000649A1/en active Application Filing
- 2002-06-18 BR BR0210468-7A patent/BR0210468A/pt not_active IP Right Cessation
- 2002-06-18 DE DE60228079T patent/DE60228079D1/de not_active Expired - Fee Related
- 2002-06-20 AR ARP020102313A patent/AR036099A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2450174A1 (en) | 2003-01-03 |
US6589970B2 (en) | 2003-07-08 |
EP1397341A1 (de) | 2004-03-17 |
TW591020B (en) | 2004-06-11 |
CN1543453A (zh) | 2004-11-03 |
AR036099A1 (es) | 2004-08-11 |
JP4394949B2 (ja) | 2010-01-06 |
BR0210468A (pt) | 2004-08-10 |
CN100467443C (zh) | 2009-03-11 |
JP2004536091A (ja) | 2004-12-02 |
MXPA03011409A (es) | 2004-06-08 |
WO2003000649A1 (en) | 2003-01-03 |
DE60228079D1 (en) | 2008-09-18 |
US20030045560A1 (en) | 2003-03-06 |
EP1397341B1 (de) | 2008-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE403643T1 (de) | 6-(aryl-amido oder aryl-amidomethyl)-naphthol-2- yloxy-säurederivate als inhibitoren des plasminogen aktivator inhibitors typ-1(pai-1) | |
NO20035635D0 (no) | Substituerte naftylindol-derivater som inhibitorer av plasminogen-aktivatorinhibitor type-1 (PAI-1) | |
DE60121550D1 (de) | Pyrimidin-4-onderivat ALS LDL-PLA2 INHIBITOR | |
ATE244235T1 (de) | Heterocyclische verbindungen als reversible inhibitoren von cysteinproteasen | |
DE60305061D1 (de) | 2-pyridonderivate als inhibitoren von neutrophiler elastase | |
DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
ATE333463T1 (de) | Selektive dipeptidische inhibitoren von kallikrein | |
ATE402930T1 (de) | Dipeptidnitrile als inhibitoren von cathepsin k | |
DE60321808D1 (de) | Flavon derivate als inhibitoren von cyclin-abhängigen kinasen | |
EE200300361A (et) | PDE4 isosüümide inhibiitoritena kasutatavad eetriderivaadid | |
NO20050199L (no) | Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet | |
DE60315862D1 (de) | Dihydropyridinonderivate als hne-inhibitoren | |
AU2002357137A8 (en) | (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase | |
DE60321324D1 (de) | Sulfonylaminoderivate als neue inhibitoren von histondeacetylase | |
PT1465864E (pt) | Inibidores de factor xa e outras serina proteases envolvidos na cascata da coagulacao | |
ATE331708T1 (de) | Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren | |
ATE323072T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
ATE281181T1 (de) | Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren | |
ME00554B (me) | KORIŠĆENJE IL-18 INHIBITORA ZA LIJEČENJE l/ILI PREVENCIJU ATEROSKLEROZE | |
DE60210612D1 (de) | N-formylhydroxylamin verbindungen als inhibitoren von pdf | |
DE60217532D1 (de) | Carboline derivate als ikb-inhibitoren zur behandlung des m ultiplen myelomas | |
ATE430726T1 (de) | N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b | |
ATE443044T1 (de) | Tace inhibitoren | |
DE60110914D1 (de) | Verbindungen und ihre verwendung als hemmer des glycintransports | |
ATE287416T1 (de) | Thrombin inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |